| Net sales |
(3) |
2,145,132 |
2,000,692 |
| Cost of sales |
(4) |
1,552,493 |
1,420,982 |
| Gross profit on sales |
|
592,639 |
579,710 |
| Selling expenses |
|
399,339 |
368,847 |
| Research and development costs |
(12) |
42,131 |
39,936 |
| General administrative expenses |
|
27,530 |
28,771 |
| Other operating income |
(7) |
16,299 |
7,141 |
| Other operating expenses |
(8) |
17,766 |
12,382 |
| Income from companies accounted for using the equity method |
|
– 812 |
2,599 |
| Other net income (loss) from investments |
(9) |
407 |
– |
| Earnings before interest and income taxes |
|
121,767 |
139,514 |
| Financial income (loss) |
(10) |
– 310 |
– 1,012 |
| Earnings before taxes |
|
121,457 |
138,502 |
| Income taxes |
(11) |
44,731 |
56,910 |
| Net income |
|
76,726 |
81,592 |
| |
|
|
|
| Earnings per share in € (diluted/undiluted) |
(38) |
2.26 |
2.40 |
